fact is we are close to having finance a done deal which is more than a few others can say. finance will not be delayed by Tanz situation and if that side clears p then we are really set to go IMO.
as for battery prices - we have first three years production sold, are constantly sending battery packs to the customers and IMO all appears to be progressing well albeit somewhat slower than one would have hoped. but all moving forward.
I have no doubt that once Tanz sorted then finance will be a given there due to the ground work already attended to as well as the SEZ licence and the advantages that brings. That will also allow cost savings in our batteries once we are able to source our own product.
looking good IMO - just fingers crossed on the finance but that seems pretty close given that there has already been a long DD time.
so all you going on about batteries what will that do to the cost of material inputs?. guess that a number of G companies may well have to decrease their profit margins as well if battery producers are to have minimal profits then I would suggest that that will put pressure on the cost of inputs which will impact on all G companies (even those that some non-holding posters hold). But we have the advantage of sourcing our own product.
- Forums
- ASX - By Stock
- MNS
- Ann: US$52M Term Sheet Signed for New York Battery Plant
Ann: US$52M Term Sheet Signed for New York Battery Plant, page-62
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNS (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online